Skip to main content
. 2024 Aug 23;12(8):e6084. doi: 10.1097/GOX.0000000000006084

Fig. 12.

Fig. 12.

TSA of trials explored the effectiveness of BTxA in facelift. The cumulative Z-curve has not crossed the RIS (120) but crossed conventional benefit boundary.